Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Graham Holdings Company Common Stock (GHC) vs Organon & Co. Common Stock (OGN) Price & Performance

Graham Holdings Company Common StockTrade
Organon & Co. Common StockTrade

Price performance (Past 24H)

Key statistics

Graham Holdings Company Common Stock vs Organon & Co. Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $5.02B), while Organon & Co. Common Stock trades at $13.73 (market cap $3.61B). The key difference: Graham Holdings Company Common Stock is the larger of the two by market cap, and Graham Holdings Company Common Stock pays the higher dividend (0.63%). Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Organon & Co. Common Stock for 0 Days on average.

GHCOGN
Market Cap
$5.02B$3.61B
Volume
21,1181,808,049
Sector
IndustrialsHealth
52-Week High
$1.23K$13.81
52-Week Low
$949.84$5.70
Typical Hold Time
0 Days0 Days
Enterprise Value
$5.12B$11.03B
Dividend Yield
0.63%0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Graham Holdings Company Common Stock

No Aura AI signal available yet.

Organon & Co. Common Stock

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GHC
100% Buy0% Sell
Avg holding period · 0 Days
OGN
100% Buy0% Sell
Avg holding period · 0 Days

About Graham Holdings Company Common Stock

Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.

Read more on GHC →

About Organon & Co. Common Stock

Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.

Read more on OGN →